BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 11744430)

  • 1. High dose oral ganciclovir treatment for cytomegalovirus retinitis.
    Lalezari JP; Friedberg DN; Bissett J; Giordano MF; Hardy WD; Drew WL; Hubbard LD; Buhles WC; Stempien MJ; Georgiou P; Jung DT; Robinson CA;
    J Clin Virol; 2002 Feb; 24(1-2):67-77. PubMed ID: 11744430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral ganciclovir for cytomegalovirus retinitis in patients with AIDS: results of two randomized studies.
    Squires KE
    AIDS; 1996 Dec; 10 Suppl 4():S13-8. PubMed ID: 9110065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus retinitis in AIDS patients: a comparative study of intravenous and oral ganciclovir as maintenance therapy.
    Danner SA; Matheron S
    AIDS; 1996 Dec; 10 Suppl 4():S7-11. PubMed ID: 9110064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
    Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group.
    Drew WL; Ives D; Lalezari JP; Crumpacker C; Follansbee SE; Spector SA; Benson CA; Friedberg DN; Hubbard L; Stempien MJ
    N Engl J Med; 1995 Sep; 333(10):615-20. PubMed ID: 7637721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis.
    Martin DF; Sierra-Madero J; Walmsley S; Wolitz RA; Macey K; Georgiou P; Robinson CA; Stempien MJ;
    N Engl J Med; 2002 Apr; 346(15):1119-26. PubMed ID: 11948271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous versus oral ganciclovir: European/Australian comparative study of efficacy and safety in the prevention of cytomegalovirus retinitis recurrence in patients with AIDS. The Oral Ganciclovir European and Australian Cooperative Study Group.
    AIDS; 1995 May; 9(5):471-7. PubMed ID: 7639972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-weekly intraocular injections of ganciclovir for maintenance therapy of cytomegalovirus retinitis: clinical and ocular outcome.
    Hodge WG; Lalonde RG; Sampalis J; DeschĂȘnes J
    J Infect Dis; 1996 Aug; 174(2):393-6. PubMed ID: 8699072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus (CMV) resistance in patients with CMV retinitis and AIDS treated with oral or intravenous ganciclovir.
    Drew WL; Stempien MJ; Andrews J; Shadman A; Tan SJ; Miner R; Buhles W
    J Infect Dis; 1999 Jun; 179(6):1352-5. PubMed ID: 10228054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Funduscopy versus photographic assessment of cytomegalovirus retinitis progression: a clinician's perspective.
    Migdal C
    AIDS; 1996 Dec; 10 Suppl 4():S19-23. PubMed ID: 9110066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incremental cost-effectiveness analysis of intravenous ganciclovir versus oral ganciclovir in the maintenance treatment of newly diagnosed cytomegalovirus retinitis in patients with AIDS.
    Rachlis A; Smaill F; Walker V; Hotchkies L; Jones A
    Pharmacoeconomics; 1999 Jul; 16(1):71-84. PubMed ID: 10539123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II dose-ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG protocol 093). AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
    Jacobson MA; Wulfsohn M; Feinberg JE; Davis R; Power M; Owens S; Causey D; Heath-Chiozzi ME; Murphy RL; Cheung TW
    AIDS; 1994 Apr; 8(4):451-9. PubMed ID: 8011248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A safety study of oral valganciclovir maintenance treatment of cytomegalovirus retinitis.
    Lalezari J; Lindley J; Walmsley S; Kuppermann B; Fisher M; Friedberg D; Lalonde R; Matheron S; Nieto L; Torriani FJ; Van Syoc R; Sutton MA; Buhles W; Stempien MJ;
    J Acquir Immune Defic Syndr; 2002 Aug; 30(4):392-400. PubMed ID: 12138345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganciclovir evaluation in AIDS patients with cytomegalovirus retinitis: a European study of treatment patterns and resource utilization.
    Hardens M
    AIDS; 1996 Dec; 10 Suppl 4():S25-30. PubMed ID: 9110067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of recurrent cytomegalovirus retinitis with the ganciclovir implant.
    Roth DB; Feuer WJ; Blenke AJ; Davis JL
    Am J Ophthalmol; 1999 Mar; 127(3):276-82. PubMed ID: 10088736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluation of systemic treatments for cytomegalovirus retinitis in patients with AIDS.
    Lee TA; Sullivan SD; Veenstra DL; Ramsey SD; Steger PJ; Malinverni R; Pleil AM; Williamson T
    Pharmacoeconomics; 2001; 19(5 Pt 2):535-50. PubMed ID: 11465299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
    Ophthalmology; 1994 Jul; 101(7):1250-61. PubMed ID: 8035989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela.
    Arevalo JF; Garcia RA; Mendoza AJ
    Eur J Ophthalmol; 2005; 15(5):610-8. PubMed ID: 16167292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial.
    Studies of Ocular Complications of AIDS Research Group. The AIDS Clinical Trials Group.
    Am J Ophthalmol; 2001 Apr; 131(4):457-67. PubMed ID: 11292409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal ganciclovir for cytomegalovirus retinitis in patients with AIDS.
    Montero MC; Pastor M; Buenestado C; Lluch A; Atienza M
    Ann Pharmacother; 1996; 30(7-8):717-23. PubMed ID: 8826547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.